Solebury Capital
Solebury Trout Updates: Biotech & Pharma ECM Summary
Solebury Capital

 

Untitled-17-990000000003cf3c.png

 

April 15, 2019

STRICTLY PRIVATE & CONFIDENTIAL

 

 

 

Biotech & Pharma ECM Summary

CLICK HERE FOR FULL REPORT

DJIA (+0.27%) | SP500  (+0.40%) | COMP (+0.38%) | NBI (-2.99%) | DRG (-2.32%)

 

 

 

Last Week

IPOs: None

 


FOs: 6 Transactions - Homology Medicines ($125M), Autolus Therapeutics ($116M), X4 Pharmaceuticals ($86M), PhaseBio Pharmaceuticals ($43M), Outlook Therapeutics ($28M), PolarityTE ($28M)

Private: 3 Transactions - Inozyme Pharma ($67M), Cullgen ($16M), Noveome Biotherapeutics ($15M)

Year-to-date

IPOs: 10 Transactions

  • Raised YTD: $1,164.14M (FY 2018: 61, $6.22B)

FOs: 41 Transactions

  • Raised YTD: $5,120.72M (FY 2018: 131, $18.43B)

 

Private: 83 Transactions

  • Raised YTD: $4,620.08M (FY 2018: 388, $13.68)

 

 

 

If you have any questions on the report or the underlying data, kindly let us know.